Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Genetically modified human adenovirus encoding human PH20 hyaluronidase

EU orphan designation number: EU/3/11/880   
Active ingredient: Genetically modified human adenovirus encoding human PH20 hyaluronidase
Indication: Treatment of pancreatic cancer
Sponsor: VCN Biosciences S.L.
Av. de la Generalitat 152, E-08174 - Sant Cugat del Vallès, Barcelona, España

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
27/06/2011 Centralised Orphan - Designation EMA/OD/008/11 (2011)4554 of 21/06/2011
12/07/2013 Other procedure